These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26510914)

  • 41. TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.
    Guerrache A; Micheau O
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strophanthidin Induces Apoptosis of Human Lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling.
    Tian X; Gu L; Zeng F; Liu X; Zhou Y; Dou Y; Han J; Zhao Y; Zhang Y; Luo Q; Wang F
    Molecules; 2024 Feb; 29(4):. PubMed ID: 38398629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sec1 regulates intestinal mucosal immunity in a mouse model of inflammatory bowel disease.
    Cai J; Wu H; Wang C; Chen Y; Zhang D; Guan S; Fu B; Jin Y; Qian C
    BMC Immunol; 2023 Dec; 24(1):51. PubMed ID: 38066482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circular RNA hsa_circ_0110389 promotes gastric cancer progression through upregulating SORT1 via sponging miR-127-5p and miR-136-5p.
    Liang M; Yao W; Shi B; Zhu X; Cai R; Yu Z; Guo W; Wang H; Dong Z; Lin M; Zhou X; Zheng Y
    Cell Death Dis; 2021 Jun; 12(7):639. PubMed ID: 34162830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling.
    Oh YT; Sun SY
    Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33810241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis.
    Zhang S; Chen Z; Shi P; Fan S; He Y; Wang Q; Li Y; Ramalingam SS; Owonikoko TK; Sun SY
    Theranostics; 2021; 11(8):3964-3980. PubMed ID: 33664875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trametinib potentiates TRAIL-induced apoptosis via FBW7-dependent Mcl-1 degradation in colorectal cancer cells.
    Lin L; Ding D; Xiao X; Li B; Cao P; Li S
    J Cell Mol Med; 2020 Jun; 24(12):6822-6832. PubMed ID: 32352219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neferine treatment enhances the TRAIL‑induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway.
    Nazim UM; Yin H; Park SY
    Int J Oncol; 2020 May; 56(5):1152-1161. PubMed ID: 32319589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox.
    Lim B; Greer Y; Lipkowitz S; Takebe N
    Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31370269
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetic Alterations of TRAF Proteins in Human Cancers.
    Zhu S; Jin J; Gokhale S; Lu AM; Shan H; Feng J; Xie P
    Front Immunol; 2018; 9():2111. PubMed ID: 30294322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer.
    Wang X; Xue Q; Wu L; Wang B; Liang H
    FEBS Open Bio; 2018 May; 8(5):732-742. PubMed ID: 29744288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kaempferol Induces G2/M Cell Cycle Arrest via Checkpoint Kinase 2 and Promotes Apoptosis via Death Receptors in Human Ovarian Carcinoma A2780/CP70 Cells.
    Gao Y; Yin J; Rankin GO; Chen YC
    Molecules; 2018 May; 23(5):. PubMed ID: 29734760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrine Inhibits Neuroblastoma Cell Proliferation and Migration by Enhancing Tribbles 3 Expression.
    Shen X; Huang J; Liu G; Zhang H; Zhang X; Kong X; Du L
    Oncol Res; 2018 Aug; 26(7):1133-1142. PubMed ID: 29386091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hsp90 inhibitor sensitizes TRAIL-mediated apoptosis via chop-dependent DR5 upregulation in colon cancer cells.
    Yao Z; Chen A; Li X; Zhu Z; Jiang X
    Am J Transl Res; 2017; 9(11):4945-4953. PubMed ID: 29218092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5.
    Oh YT; Deng L; Deng J; Sun SY
    Sci Rep; 2017 Aug; 7(1):8027. PubMed ID: 28808321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. North African Medicinal Plants Traditionally Used in Cancer Therapy.
    Alves-Silva JM; Romane A; Efferth T; Salgueiro L
    Front Pharmacol; 2017; 8():383. PubMed ID: 28694778
    [No Abstract]   [Full Text] [Related]  

  • 57. DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion.
    Oh YT; Yue P; Sun SY
    Cell Commun Signal; 2017 May; 15(1):18. PubMed ID: 28482915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition.
    Yao W; Oh YT; Deng J; Yue P; Deng L; Huang H; Zhou W; Sun SY
    J Biol Chem; 2016 Oct; 291(41):21694-21702. PubMed ID: 27576686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells.
    Oh YT; Deng J; Yue P; Sun SY
    Sci Rep; 2016 May; 6():26803. PubMed ID: 27222248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling.
    Oh YT; Yue P; Wang D; Tong JS; Chen ZG; Khuri FR; Sun SY
    Oncotarget; 2015 Dec; 6(38):41324-38. PubMed ID: 26510914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.